Nurturing baby steps in drug development
Nurturing slow and steady progress is the key to successful drug development, rather than relying on breakthroughs, according to a report from the Association of the British Pharmaceutical Industry (ABPI).
Archives for April 22, 2007
Promed's Indian injectables plant opens
Indian contract manufacturer Promed has finally opened its newly-built parenteral manufacturing plant in Himachal Pradeshon, India.
BioFocus on a primary path to screening
BioFocus DPI is developing a drug screening service that will use primary cells in an attempt to improve pharma productivity, although first it must persuade the industry that the technique is reliable.
BioProgress nudges into profit with new market-driven profile
A new market-oriented approach to product development, more favourable licensing arrangements, strategic acquisitions and a fresh crop of proprietary drug-delivery technologies helped UK company BioProgress to deliver an adjusted operating profit for...
Pharmaceutical industry biding its time on RFID adoption
While technology cost and lack of a demonstrated return on investment constitute the biggest barrier to adoption of radio frequency identification (RFID) in the pharmaceutical industry, the lack of a frequency standard runs these factors a close...
Novartis licences lead cancer candidate from Antisoma
Novartis has licensed a potential first-in-class vascular disrupting agent from Antisoma in a deal worth up to $890m (€656m), highlighting the company's increasing focus on the oncology market.